Search

#HealthcareAccess
The New York Times @nytimes.com Β· New York City πŸ‡ΊπŸ‡Έ Β· 15h

A recent study published in JAMA Oncology reveals that over half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments due to various barriers such as late diagnoses, access issues, stigma, and a lack of oncologist consultations, despite the availability of promising new therapies that have significantly improved treatment outcomes for this deadly disease. #LungCancer #CancerTreatment #HealthcareAccess #US #CO #TX

www.nytimes.com
About Half of Patients with Metastatic Lung Cancer Don't Get Treatment, Study Finds
New drugs have made America's deadliest cancer more treatable than ever. So why aren't they reaching patients. More than half of patients with metastatic lung cancer don't receive life-extending treatments, like chemotherapy, immunotherapy and targeted therapy, a new study found.
The New York Times @nytimes.com Β· New York City πŸ‡ΊπŸ‡Έ Β· 19h

A recent study published in JAMA Oncology revealed that over half of patients with metastatic lung cancer, despite the availability of new, effective treatments, do not receive life-extending therapies due to various barriers such as access issues, late diagnoses, stigma, and lack of oncologist consultations, highlighting a significant gap in care for this deadly disease. #LungCancer #CancerTreatment #HealthcareAccess #US

www.nytimes.com
About Half of Patients with Metastatic Lung Cancer Don't Get Treatment, Study Finds
New drugs have made America's deadliest cancer more treatable than ever. So why aren't they reaching patients. More than half of patients with metastatic lung cancer don't receive life-extending treatments, like chemotherapy, immunotherapy and targeted therapy, a new study found.
The New York Times @nytimes.com Β· New York City πŸ‡ΊπŸ‡Έ Β· 20h

A recent study highlights that despite advancements in treatments for metastatic lung cancer, over half of patients do not receive life-extending therapies due to various barriers such as access issues, misconceptions about the disease, and the stigma associated with smoking, emphasizing the need for improved patient access to oncologists and education about available treatments. #LungCancer #CancerTreatment #HealthCareAccess #US

www.nytimes.com
About Half of Patients with Metastatic Lung Cancer Don't Get Treatment, Study Finds
New drugs have made America's deadliest cancer more treatable than ever. So why aren't they reaching patients. More than half of patients with metastatic lung cancer don't receive life-extending treatments, like chemotherapy, immunotherapy and targeted therapy, a new study found.
The New York Times @nytimes.com Β· New York City πŸ‡ΊπŸ‡Έ Β· 2d

The closure of Bonner General Health's labor and delivery services in Sandpoint, Idaho, has left pregnant women with limited options for prenatal and postpartum care, prompting many to seek home births or travel long distances to hospitals, while highlighting a broader crisis in rural maternity care across the U.S., where over 130 labor and delivery units have shut down since 2020, thereby increasing the risk of emergencies and inadequate care. #RuralHealth #MaternityCare #HealthcareAccess #US #ID #WA #ME #OR #CA #VT #TX #VE

www.nytimes.com
Opinion | You Can't Be Born Here. You Can Only Die.
When Bonner General Health stopped providing labor and delivery services in 2023, the families of Sandpoint, Idaho, were devastated.
The New York Times @nytimes.com Β· New York City πŸ‡ΊπŸ‡Έ Β· 2d

The closure of Bonner General Health's labor and delivery services in Sandpoint, Idaho, has left local families facing limited options for prenatal and postpartum care, forcing many to seek alternatives like home births or travel long distances to hospitals, amidst a broader nationwide trend of rural maternity care deserts, exacerbated by systemic issues in healthcare funding and staffing shortages. #RuralHealth #MaternalCare #HealthcareAccess #US #ID #WA #ME #OR #CA #GU #VZ

www.nytimes.com
Opinion | You Can't Be Born Here. You Can Only Die.
When Bonner General Health stopped providing labor and delivery services in 2023, the families of Sandpoint, Idaho, were devastated.
R
Reuters @reuters.com Β· London πŸ‡¬πŸ‡§ Β· 3d

Since its launch in June, the usage of Gilead Sciences' Yeztugo, a twice-yearly injection for HIV prevention, has increased, but many patients face challenges such as insurance coverage gaps and a preference for daily pills over the injectable option. #HIVPrevention #PrEP #HealthcareAccess #US

www.reuters.com
Focus: Use of Gilead's HIV prevention shot rises, but US insurance gaps remain
May 5 (Reuters) - Use of Gilead Sciences' (GILD. O), opens new tab Yeztugo, a twice-yearly injection to prevent HIV infection, has climbed since its June launch, but U.